Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
4.410
-0.120 (-2.65%)
At close: Dec 20, 2024, 4:00 PM
4.130
-0.280 (-6.35%)
After-hours: Dec 20, 2024, 4:33 PM EST
Aptevo Therapeutics Market Cap
Aptevo Therapeutics has a market cap or net worth of $2.21 million as of December 20, 2024. Its market cap has decreased by -35.10% in one year.
Market Cap
2.21M
Enterprise Value
-16.56K
1-Year Change
-35.10%
Ranking
Category
Stock Price
$4.41
Market Cap Chart
Since July 20, 2016, Aptevo Therapeutics's market cap has decreased from $161.90M to $2.21M, a decrease of -98.64%. That is a compound annual growth rate of -39.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 2.20M | -31.25% |
| Dec 29, 2023 | 3.20M | -72.88% |
| Dec 30, 2022 | 11.80M | -69.43% |
| Dec 31, 2021 | 38.60M | -74.59% |
| Dec 31, 2020 | 151.90M | 413.18% |
| Dec 31, 2019 | 29.60M | 2.78% |
| Dec 31, 2018 | 28.80M | -68.28% |
| Dec 29, 2017 | 90.80M | 83.81% |
| Dec 30, 2016 | 49.40M | -69.49% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shuttle Pharmaceuticals Holdings | 2.35M |
| Venus Concept | 2.34M |
| Palisade Bio | 2.33M |
| Biodexa Pharmaceuticals | 2.32M |
| Salarius Pharmaceuticals | 2.23M |
| Dermata Therapeutics | 2.20M |
| NanoVibronix | 2.18M |
| Bluejay Diagnostics | 2.06M |